17.04.2017 Views

Hypoparathyroidism Market Trends, Analysis and Forecasts 2016

Fibrodysplasia ossificans progressiva (FOP) is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone (ossified), forming bone outside that constrains movement.

Fibrodysplasia ossificans progressiva (FOP) is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone (ossified), forming bone outside that constrains movement.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Hypoparathyroidism</strong> <strong>Market</strong> Pipeline Review<br />

<strong>and</strong> Forecast Report <strong>2016</strong><br />

“<strong>Hypoparathyroidism</strong> is decreased function of the<br />

parathyroid gl<strong>and</strong>s with underproduction of<br />

parathyroid hormone.”<br />

Summary<br />

Radiant Insights's latest Pharmaceutical <strong>and</strong> Healthcare disease pipeline guide <strong>Hypoparathyroidism</strong><br />

- Pipeline Review, H2 <strong>2016</strong>, provides an overview of the <strong>Hypoparathyroidism</strong> (Hormonal Disorders)<br />

pipeline l<strong>and</strong>scape.<br />

<strong>Hypoparathyroidism</strong> is decreased function of the parathyroid gl<strong>and</strong>s with underproduction of<br />

parathyroid hormone. This leads to low levels of calcium in the blood, often causing cramping <strong>and</strong><br />

twitching of muscles (involuntary muscle contraction), <strong>and</strong> several other symptoms. The condition<br />

can be inherited, but it is also encountered after thyroid or parathyroid gl<strong>and</strong> surgery, <strong>and</strong> it can be<br />

caused by immune system-related damage as well as a number of rarer causes. The treatment<br />

includes artificial form of the hormone that can be administered as replacement, calcium<br />

replacement or vitamin.<br />

Complete Report Available @<br />

http://www.radiantinsights.com/research/hypoparathyroidism-pipeline-review-h2-<strong>2016</strong><br />

Report Highlights<br />

Radiant Insights's Pharmaceutical <strong>and</strong> Healthcare latest pipeline guide <strong>Hypoparathyroidism</strong> -<br />

Pipeline Review, H2 <strong>2016</strong>, provides comprehensive information on the therapeutics under<br />

Follow Us:


development for <strong>Hypoparathyroidism</strong> (Hormonal Disorders), complete with analysis by stage of<br />

development, drug target, mechanism of action (MoA), route of administration (RoA) <strong>and</strong> molecule<br />

type. The guide covers the descriptive pharmacological action of the therapeutics, its complete<br />

research <strong>and</strong> development history <strong>and</strong> latest news <strong>and</strong> press releases.<br />

The <strong>Hypoparathyroidism</strong> (Hormonal Disorders) pipeline guide also reviews of key players involved in<br />

therapeutic development for <strong>Hypoparathyroidism</strong> <strong>and</strong> features dormant <strong>and</strong> discontinued projects.<br />

The guide covers therapeutics under Development by Companies /Universities /Institutes, the<br />

molecules developed by Companies in Pre-Registration, Phase II, Phase I <strong>and</strong> Preclinical stages are<br />

1, 1, 1 <strong>and</strong> 4 respectively.<strong>Hypoparathyroidism</strong>.<br />

<strong>Hypoparathyroidism</strong> (Hormonal Disorders) pipeline guide helps in identifying <strong>and</strong> tracking emerging<br />

players in the market <strong>and</strong> their portfolios, enhances decision making capabilities <strong>and</strong> helps to create<br />

effective counter strategies to gain competitive advantage. The guide is built using data <strong>and</strong><br />

information sourced from Radiant Insights's proprietary databases, company/university websites,<br />

clinical trial registries, conferences, SEC filings, investor presentations <strong>and</strong> featured press releases<br />

from company/university sites <strong>and</strong> industry-specific third party sources. Additionally, various<br />

dynamic tracking processes ensure that the most recent developments are captured on a real time<br />

basis.<br />

Request a Sample Copy of This Report @<br />

http://www.radiantinsights.com/research/fibrodysplasia-ossificans-progressivamyositis-ossificans-progressiva-pipeline-review-h2-<strong>2016</strong>/request-sample<br />

Scope<br />

- The pipeline guide provides a snapshot of the global therapeutic l<strong>and</strong>scape of <strong>Hypoparathyroidism</strong><br />

(Hormonal Disorders).<br />

- The pipeline guide reviews pipeline therapeutics for <strong>Hypoparathyroidism</strong> (Hormonal Disorders) by<br />

companies <strong>and</strong> universities/research institutes based on information derived from company <strong>and</strong><br />

industry-specific sources.<br />

- The pipeline guide covers pipeline products based on several stages of development ranging from<br />

pre-registration till discovery <strong>and</strong> undisclosed stages.<br />

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise,<br />

product description, descriptive licensing <strong>and</strong> collaboration details, R&D brief, MoA & other<br />

developmental activities.<br />

- The pipeline guide reviews key companies involved in <strong>Hypoparathyroidism</strong> (Hormonal Disorders)<br />

therapeutics <strong>and</strong> enlists all their major <strong>and</strong> minor projects.<br />

- The pipeline guide evaluates <strong>Hypoparathyroidism</strong> (Hormonal Disorders) therapeutics based on<br />

mechanism of action (MoA), drug target, route of administration (RoA) <strong>and</strong> molecule type.<br />

Follow Us:


- The pipeline guide encapsulates all the dormant <strong>and</strong> discontinued pipeline projects.<br />

- The pipeline guide reviews latest news related to pipeline therapeutics for <strong>Hypoparathyroidism</strong><br />

(Hormonal Disorders)<br />

See More Reports of This Category by Radiant Insights @<br />

http://www.radiantinsights.com/catalog/pharmaceuticals-<strong>and</strong>-healthcare<br />

About Radiant Insights, Inc:<br />

Radiant Insights is a platform for companies looking to meet their market<br />

research <strong>and</strong> business intelligence requirements. We assist <strong>and</strong> facilitate<br />

organizations <strong>and</strong> individuals procure market research reports, helping them in<br />

the decision making process. We have a comprehensive collection of reports,<br />

covering over 40 key industries <strong>and</strong> a host of micro markets. In addition to over<br />

extensive database of reports, our experienced research coordinators also offer a<br />

host of ancillary services such as, research partnerships/ tie-ups <strong>and</strong> customized<br />

research solutions.<br />

Contact Details:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

Radiant Insights, Inc<br />

28 2nd Street, Suite 3036, San Francisco, CA 94105, United States<br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Email: sales@radiantinsights.com<br />

Web: http://www.radiantinsights.com/<br />

Visit Our Blog: http://radiantinsightinc.blogspot.in/<br />

Follow Us:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!